[1]张孝玲 肖谦.射血分数保留性心力衰竭的治疗进展[J].心血管病学进展,2020,(11):1164-1167.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
　ZHANG Xiaoling,XIAO Qian.Therapeutic Options for Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(11):1164-1167.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
点击复制

射血分数保留性心力衰竭的治疗进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年11期
页码:
1164-1167
栏目:
综述
出版日期:
2020-11-25

文章信息/Info

Title:
Therapeutic Options for Heart Failure with Preserved Ejection Fraction
文章编号:
202004066
作者:
张孝玲 肖谦
(重庆医科大学附属第一医院老年病科,重庆 400016)
Author(s):
ZHANG Xiaoling; XIAO Qian
(Department of Geriatrics,The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
关键词:
心力衰竭; 保留射血分数; 进展; 综述
Keywords:
Heart failure; Preserved ejection fraction; Progress; Clinical review
DOI:
10.16806/j.cnki.issn.1004-3934.2020.11.000
摘要:
射血分数保留性心力衰竭异质性强，存在功能和结构损伤的多样性，逐渐成为心力衰竭的主要形式。由于缺乏充分的循证医学证据，也缺乏统一的治疗指南，因此，临床医生面临着巨大的挑战，是心脏病学亟需解决的问题。现将射血分数保留性心力衰竭的最新研究与潜在的治疗靶点联系起来，从血流动力学及分子细胞水平综述该病的治疗进展。
Abstract:
The heterogeneity of heart failure with preserved ejection fraction(HFpEF) is strong,and there is diversity of functional and structural damages.Thus，it’s becoming the dominant form of heart failure.Because of the lack of the evidence of evidence-based medicine and a consensus recommendation,clinicians are facing enormous challenges, which makes it a pressing issue in Cardiology today.Recent research on HFpEF has been linked to potential therapeutic targets,and advances in the treatment of HFpEF at the hemodynamics and molecular cellular levels are reviewed in this article

相似文献/References:

[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
　DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(11):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
　LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(11):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
　ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(11):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
　LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(11):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
　KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(11):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
　SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(11):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
　XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
　GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(11):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
　HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
　WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]

更新日期/Last Update: 2021-02-03